$311.79+20.98% · 3M
Moving avg
1W-4.06%
1M+1.23%
3M+19.06%
6M-13.38%
YTD-7.99%
1Y+6.48%
3Y+68.14%
5Y+159.67%
52-week range
$244.8250% of range$377.54
Company health
Value4/6
Growth5/6
Profitability3/6
Health1/6
Dividend4/6
Bull vs bear
Strengths
- Analysts see 15% upside to a $359 target
- Analyst consensus is "Buy"
- High return on equity (11593%)
Risks
- Highly leveraged (debt is 7.1x equity)
Key statistics
Valuation
Market cap
$60.66B
Enterprise value
$70.44B
P/E ratio (TTM)
23.62x
P/S ratio (TTM)
0.18x
EV/EBITDA
14.10x
Per share & returns
EPS (TTM)
$13.10
Dividend yield
0.76%
Beta (1Y)
0.58
30-day change
+1.23%
Trading
Volume (24h)
556.41K
Previous close
$310.01
Shares outstanding
194.56M
About Cencora, Inc.
Sector
Healthcare
Industry
Medical - Distribution
Exchange
NYSE
Symbol
COR
Cencora, Inc. is a large-cap healthcare company in the Medical - Distribution industry. Its shares are listed on NYSE (United States) and trade under the ticker COR.
Frequently asked questions
What is Cencora, Inc.'s market cap?
Cencora, Inc. (COR) has a market capitalization of $60.66B.
What is Cencora, Inc.'s P/E ratio?
Cencora, Inc. trades at a price-to-earnings (P/E) ratio of 23.62.
What exchange does COR trade on?
COR trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,183.96-2.07%
$1.11T cap
Johnson & JohnsonJNJ
$260.74-0.51%
$628.36B cap
AbbVie Inc.ABBV
$250.08-0.30%
$441.84B cap
UnitedHealth Group IncorporatedUNH
$402.33+0.82%
$365.37B cap
Roche Holding AGSWX: ROP
CHF 355.10-1.99%
$348.28B cap
Merck & Co., Inc.MRK
$134.46-0.80%
$332.09B cap
Novartis AGSWX: NOVN
CHF 122.44-1.05%
$286.75B cap
AstraZeneca PLCLON: AZN
£114.60-2.12%
$240.91B cap